How should we detect and manage failed thrombolysis?

European Heart Journal

Volumn 22, Issue 6, 2001, Pages 450-457

  Kovac, J D ^a   Gershlick, A H ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; CREATINE KINASE ISOENZYME; CREATINE KINASE MB; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MYOGLOBIN; RETEPLASE; STREPTOKINASE; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DILATATION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; COUNTERPULSATION; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART MUSCLE REPERFUSION; HUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; ST SEGMENT ELEVATION; THORAX PAIN; THROMBECTOMY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; TREATMENT FAILURE;

EID: 0034931161     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.2047     Document Type: Review

References (64)

1. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
2. Meta analysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction
3. From myocardial salvage to patient salvage in acute myocardial infarction, the role of reperfusion therapy
4. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction, the Primary Angioplasty in Myocardial Infarction Study Group
5. A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction
6. Characteristics and outcome of patients in whom reperfusion with intravenous tissue type plasminogen activator fails: Results of the thrombolysis and angioplasty in myocardial infarction (TAMI IV)
7. Applying the open artery theory: Use of predictive survival markers
8. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries
9. Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: Improved timing, thrombolytic efficacy and ventricular function
10. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy of acute myocardial infarction
11. Guidelines for the management of patiens with acute myocardial infarction
12. A comparison of management patterns after acute myocardial infarction in Canada and the United States
13. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis
14. ISIS 3: A randomized trial of streptokinase vs tissue plasminogen activator vs antistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
15. Failure of reperfusion following thrombolysis in acute myocardial infarction: A survey of current views and clinical practice
16. What do we do when thrombolysis fails? A United Kingdom survey
17. Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
18. Measurement of pain
19. Use of changes in ST segment elevation for prediction of infarct artery recanalization in acute myocardial infarction
20. Change in ST segment elevation 60 min after thrombolysis initiation predicts clinical outcome as accurately as later changes
21. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in GUSTO I trial
22. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction
23. Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction
24. Non invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: Importance of measurement of peak levels
25. The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion
26. Rescue thrombolysis: Alteplase as adjuvant treatment after streptokinase in acute myocardial infarction
27. Rescue angioplasty after failed thrombolysis: Technical and clinical outcomes in a large thrombolysis trial
28. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute myocardial infarction
29. Myocardial scintigraphy in acute myocardial infarction treated with systemic thrombolysis: How far are we from obtaining reliable information for rescue PTCA?
30. Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: Relation to timing and extent of functional recovery
31. Myocardial contrast echocardiography in acute myocardial infarction: Time to test for routine clinical use?
32. 'Rescue' thrombolysis with intracoronary tissue plasminogen activator for failed thrombolysis with streptokinase for acute myocardial infarction
33. An angiographic study of intracoronary streptokinase versus intravenous tissue plasminogen activator after failed coronary thrombolysis with intravenous streptokinase
34. Rescue thrombolysis may work even though primary thrombolysis has failed
35. Importance of time to reperfusion for 30 day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction
36. Toward a new frontiers in myocardial reperfusion therapy, emerging platelet preeminence
37. Catheter based reperfusion for acute myocardial infarction
38. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: Observations in animals and humans
39. Rescue angioplasty during myocardial infarction has a beneficial effect on mortality: A tenable hypothesis
40. Management of myocardial infarction patients with an occluded infarct related artery: Additional commentary
41. Rescue angioplasty in Thrombolysis in myocardial infarction (TIMI IV) trial
42. A matched comparison of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty
43. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on 6 week left ventricular function
44. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI)
45. Transfer of high risk myocardial infarction patients for primary PTCA
46. Transferring patients for primary angioplasty, a retrospective analysis of 104 selected high risk patients with acute myocardial infarction
47. Importance of time to reperfusion for 30 day and late survival and recovery of left ventricular function after primary PTCA for acute myocardial infarction
48. Early referral for intentional rescue PTCA after initiation of thrombolytic therapy in patients admitted to a community hospital because of a large acute myocardial infarction
49. Experience with salvage angioplasty in a regional cardiothoracic centre using a 'Hub and Spoke' referral system
50. Retrieval angioplasty for acute myocardial infarction. An alternative which makes sense
51. The Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI study
52. Pulse spray thrombolysis in acutely obstructed coronary artery in critical situations
53. Transluminal extrraction catheter for acute myocardial infarction
54. Prospective study of extraction atherectomy in patients with acute myocardial infarction
55. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE) trial. Results of the feasibility phase
56. Catheter based ultrasound thrombolysis
57. The lipid peroxidation inhibitor indenoindole H290/51 protects myocardium at risk of injury induced by ischemia reperfusion
58. Apoptosis is prevented by administration of superoxide dismutase in dogs with reperfused myocardial infarction
59. Antioxidant activity of U-83836, a second generation lazaroid, during myocardial ischemia/reperfusion injury
60. Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction
61. Intraaortic balloon pumping as adjunctive therapy to rescue coronary angioplasty after failed thrombolysis in anterior wall acute myocardial infarction
62. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy
63. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous coronary angioplasty. Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) study
64. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial)